explore -WSS

explore

author：hotspot 2025-09-27 22:18:15 - browse：54817

The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it also exposed how complicated and vital these electronic pipes are.

Using terms like “clearinghouse” and “electronic data interchange” are quick ways to lose an audience. But Ben Handel, a health economist at the University of California, Berkeley, for the past 13 years, has become intimately familiar with that language. When the Department of Justice sued to block UnitedHealth’s acquisition of Change Healthcare in 2022 — a case the agency ultimately lost — Handel was the government’s witness to explain what could happen to the payments and clearinghouse markets if the deal went through.

He didn’t get into health economics to study the payment plumbing system, but understanding basic concepts about companies like Change Healthcare can illuminate the gravity of what is going on now. For example, the cyberattack and resulting outage isn’t just leading to a cash crunch for providers. It’s also creating uncertainty about how to handle basic requests to approve drugs and care and verify patients’ insurance.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

knowledge

leisure time

WSS

CVS, Rite Aid closures threaten to worsen pharmacy deserts

A letter from the executive editor: STAT UnitedHealth investigation

Healthy food access boosts outcomes in two studies

RaDonda Vaught links Vanderbilt hospital issues to patient death

As AI in medicine takes off, can 'human in the loop' prevent harm?

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

knowledge

explore

focus

Medicare details structure of new drug price negotiation program

Publishing genetic code of viruses could cause disaster

Medical records are filled with copy

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Supreme Court strikes down use of affirmative action

Steward Health Care Massachusetts hospitals face fiscal disaster

United colonoscopy coverage change 'may cost lives,' doctors say

Carbon Health diabetes program, a test of data

entertainment

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Ventyx halts psoriasis drug development after lackluster trial results

How many hemophilia patients actually want gene therapy?

After decades in use, heart stents finally beat placebo

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

focus

knowledge

leisure time

leisure time